 | This article provides insufficient context for those unfamiliar with the subject. (March 2021) |
Hebei Yuxing Bio-Engineering Co. Ltd is a Chinese active pharmaceutical ingredient (API) company that exports to the United States of America. [1] Recently, the US FDA issued a warning letter due to "evidence that the company was keeping incomplete documentation and did not adequately investigate instances of microbial contamination." [2]
References
- ^ Mezher, Michael (27 September 2016). "The Rooms Have Never Been Cleaned': Two New FDA Warning Letters for Chinese Manufacturers". RAPS. Retrieved 28 September 2016.
- ^ "Hebei Yuxing Bio-Engineering Co Ltd 9/6/16 - Warning Letter 320-16-31". US FDA. 6 September 2016. Retrieved 28 September 2016.
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
 | This Chinese corporation or company article is a stub. You can help Wikipedia by expanding it. |
| This article provides insufficient context for those unfamiliar with the subject. (March 2021) |
Hebei Yuxing Bio-Engineering Co. Ltd is a Chinese active pharmaceutical ingredient (API) company that exports to the United States of America. [1] Recently, the US FDA issued a warning letter due to "evidence that the company was keeping incomplete documentation and did not adequately investigate instances of microbial contamination." [2]
References
- ^ Mezher, Michael (27 September 2016). "The Rooms Have Never Been Cleaned': Two New FDA Warning Letters for Chinese Manufacturers". RAPS. Retrieved 28 September 2016.
- ^ "Hebei Yuxing Bio-Engineering Co Ltd 9/6/16 - Warning Letter 320-16-31". US FDA. 6 September 2016. Retrieved 28 September 2016.
|
| This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
|
| This Chinese corporation or company article is a stub. You can help Wikipedia by expanding it. |